Evidence reviews on memory, focus, and brain health.
14 claims reviewed
Moderate evidence suggests bilingualism may delay dementia onset by 4-5 years. Retrospective clinical studies consistently show later symptom presentation in bilinguals, potentially reflecting cognitive reserve, though selection bias and confounders limit causal certainty.
Weak evidence suggests chewing gum may produce small, transient improvements in sustained attention and alertness, but effects on broader concentration and cognitive performance are inconsistent across studies and likely too small to be practically meaningful.
Strong evidence supports choline's role in brain development, particularly during pregnancy and early childhood. Maternal choline supplementation improves infant cognitive outcomes, and adequate intake is critical for fetal neural tube closure, hippocampal development, and myelination.
Moderate-to-strong evidence supports that higher cognitive reserve (education, occupational complexity, leisure activities) delays the clinical onset of Alzheimer's symptoms, though it does not prevent underlying neuropathology and may be associated with faster decline once symptoms appear.
Limited evidence suggests computerized cognitive training may produce modest improvements in trained cognitive domains, but claims of dementia prevention are not well-supported. Transfer to real-world function and long-term neuroprotection remain unproven.
Moderate evidence from cross-country studies suggests retirement is associated with faster cognitive decline, particularly in memory, though the relationship is complex and may depend on pre-retirement occupation type and post-retirement activities.
Moderate evidence suggests CPAP therapy can partially reverse white matter damage and cognitive deficits caused by obstructive sleep apnea. Neuroimaging studies show structural improvements after 3-12 months of consistent use, though full reversal is unlikely in severe cases.
Weak evidence that fish oil (omega-3 fatty acids) improves cognitive function in healthy adults. While DHA is a major structural component of the brain, supplementation trials in cognitively healthy adults consistently show no significant improvements in memory, attention, or processing speed. Benefits are more evident in deficient populations and older adults with mild cognitive decline.
Weak evidence suggests lion's mane (Hericium erinaceus) may support nerve growth factor production and show modest cognitive benefits in elderly with mild cognitive impairment, but human evidence is very limited.
Weak evidence supports magnesium L-threonate for cognitive improvement. Animal studies are promising for brain magnesium elevation, but human clinical trials are very limited, small, and insufficient to support popular claims about enhanced memory and cognition.
Moderate evidence from neuroimaging studies suggests experienced meditators show reduced default mode network (DMN) activity during meditation, particularly in the posterior cingulate cortex and medial prefrontal cortex. However, findings are inconsistent across studies, and the clinical significance of DMN modulation remains unclear.
Limited evidence suggests fetuses can perceive and form memory traces of sounds heard prenatally, but claims that this translates to meaningful developmental benefits are largely unsupported. The evidence is preliminary, with very small studies and substantial methodological concerns.
Conflicting evidence. Some neuroimaging studies show structural differences in children with high screen time (thinner cortex, altered white matter), but causation is unclear and effect sizes are small. Content type and displacement of other activities likely matter more than screen time per se. The field is hampered by methodological challenges.
Moderate evidence from neuroimaging studies suggests that experienced meditators show reduced default mode network (DMN) activity during meditation and altered DMN connectivity at rest. However, the field suffers from small sample sizes, methodological inconsistencies, and concerns about overinterpretation of preliminary neuroimaging findings.